Sources of interracial variation in bone mineral density.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 7785457)

Published in J Bone Miner Res on March 01, 1995

Authors

T Cundy1, J Cornish, M C Evans, G Gamble, J Stapleton, I R Reid

Author Affiliations

1: Department of Medicine, University of Auckland Medical School, New Zealand.

Associated clinical trials:

One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267

Articles citing this

Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox. J Bone Miner Res (2009) 1.76

Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int (2011) 1.44

Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women. J Bone Miner Res (2011) 1.34

Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis. Osteoporos Int (1997) 1.06

A referent bone mineral density database for Chinese American women. Osteoporos Int (2006) 1.05

Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J Natl Med Assoc (2005) 1.02

Bone mineral density reference norms for Hong Kong Chinese. Osteoporos Int (2005) 1.00

Effects of sports training & nutrition on bone mineral density in young Indian healthy females. Indian J Med Res (2011) 0.97

A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures. Osteoporos Int (2013) 0.94

The epidemiology of hip fracture in Asia: an update. Osteoporos Int (1996) 0.93

Evaluation of compressive strength index of the femoral neck in Caucasians and chinese. Calcif Tissue Int (2010) 0.92

Areal and volumetric bone density in Hong Kong Chinese: a comparison with Caucasians living in the United States. Osteoporos Int (2003) 0.91

Differences in peak bone mass in women of European and South Asian origin can be explained by differences in body size. Osteoporos Int (2005) 0.86

Bone mineral density in ethnic Norwegians and Pakistani immigrants living in Oslo--The Oslo Health Study. Osteoporos Int (2004) 0.85

Major osteoporotic fragility fractures: Risk factor updates and societal impact. World J Orthop (2016) 0.84

Differences in hip axis and femoral neck length in premenopausal women of Polynesian, Asian and European origin. Osteoporos Int (1997) 0.82

Large increases in adipose triacylglycerol flux in Cushingoid CRH-Tg mice are explained by futile cycling. Am J Physiol Endocrinol Metab (2012) 0.79

Prevalence of osteoporosis and fractures in a migrant population from southern to northern Italy: a cross-sectional, comparative study. Osteoporos Int (2003) 0.77

Relationship of body surface area with bone density and its risk of osteoporosis at various skeletal regions in women of mainland China. Osteoporos Int (2004) 0.77

Differences in bone quality and strength between Asian and Caucasian young men. Osteoporos Int (2016) 0.77

Lean Mass and Body Fat Percentage Are Contradictory Predictors of Bone Mineral Density in Pre-Menopausal Pacific Island Women. Nutrients (2016) 0.75

Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int (2016) 0.75

Articles by these authors

A new ferredoxin-dependent carbon reduction cycle in a photosynthetic bacterium. Proc Natl Acad Sci U S A (1966) 5.73

Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. Br Med J (Clin Res Ed) (1983) 3.64

Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ (1991) 3.34

Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med (1993) 3.31

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99

Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med (1995) 2.59

Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med (2000) 2.48

The synthesis of alpha-ketoglutarate from succinate and carbon dioxide by a subcellular preparation of a photosynthetic bacterium. Proc Natl Acad Sci U S A (1965) 2.27

Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. Eur Heart J (2002) 2.13

Can anti-smoking television advertising affect smoking behaviour? controlled trial of the Health Education Authority for England's anti-smoking TV campaign. Tob Control (2000) 2.06

Relation between increase in length of hip axis in older women between 1950s and 1990s and increase in age specific rates of hip fracture. BMJ (1994) 2.03

Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) Arch Gen Psychiatry (1999) 1.94

Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol (2002) 1.93

Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology (2006) 1.83

Testosterone therapy in glucocorticoid-treated men. Arch Intern Med (1996) 1.82

The synthesis of phosphoendolpyruvate from pyruvate and ATP by extracts of photosynthetic bacteria. Biochem Biophys Res Commun (1966) 1.80

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J Am Coll Cardiol (1997) 1.79

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med (1996) 1.77

Photoreduction of ferredoxin and its use in carbon dioxide fixation by a subcellular system from a photosynthetic bacterium. Proc Natl Acad Sci U S A (1965) 1.77

Regular exercise dissociates fat mass and bone density in premenopausal women. J Clin Endocrinol Metab (1995) 1.75

Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet (1991) 1.67

Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass. J Clin Endocrinol Metab (1992) 1.66

Meta-analysis: Alvimopan vs. placebo in the treatment of post-operative ileus. Aliment Pharmacol Ther (2006) 1.66

Iron-sulphur proteins. Nature (1969) 1.66

Breath-holding endurance as a predictor of success in smoking cessation. Addict Behav (1987) 1.66

Determinants of vitamin D status in older men living in a subtropical climate. Osteoporos Int (2006) 1.60

Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ (1994) 1.60

Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol (1996) 1.59

Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab (1992) 1.58

Role of proton motive force in phototactic and aerotactic responses of Rhodopseudomonas sphaeroides. J Bacteriol (1985) 1.56

Thrombolysis in acute myocardial infarction: reducing in hospital treatment delay. N Z Med J (1995) 1.55

Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berl) (1992) 1.53

Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int (2006) 1.52

The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women. J Clin Endocrinol Metab (1991) 1.51

Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol (1998) 1.51

Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48

Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl) (1996) 1.48

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant (2007) 1.47

Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP. J Nucl Med (1990) 1.47

Perinatal mortality in Type 2 diabetes mellitus. Diabet Med (2000) 1.45

Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis (2008) 1.44

Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax (1993) 1.43

Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Intern Med (1994) 1.43

Short-term effects of high dose oral medroxyprogesterone acetate on bone density in premenopausal women. J Clin Endocrinol Metab (1996) 1.43

The acromegalic rosary. Lancet (1991) 1.43

New dimensions in cause of death statistics. Am J Public Health (1982) 1.42

Comparison of pentobarbital alone and pentobarbital in combination with lidocaine for euthanasia of dogs. J Am Vet Med Assoc (1993) 1.42

Calcium supplements and cardiovascular risk in the Women's Health Initiative. Osteoporos Int (2013) 1.42

The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med (1986) 1.42

Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial. Arch Fam Med (1993) 1.41

Osteoporosis management. N Z Med J (1992) 1.40

Report of successful desensitization to itraconazole. J Allergy Clin Immunol (1994) 1.39

Methylation-independent and methylation-dependent chemotaxis in Rhodobacter sphaeroides and Rhodospirillum rubrum. J Bacteriol (1987) 1.38

A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol (1998) 1.37

Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology (2006) 1.36

Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ (1996) 1.36

Determinants of the rate of bone loss in normal postmenopausal women. J Clin Endocrinol Metab (1994) 1.34

Physiological electron donor systems to the nitrogenase of the blue-green alga Anabaena cylindrica. Biochim Biophys Acta (1971) 1.32

An e.x.a.f.s. study of the manganese O2-evolving complex in purified Photosystem II membrane fractions. The S1 and S2 states. Biochem J (1992) 1.30

Determination of the oxidation-reduction potential of the bound iron-sulphur proteins of the primary electron acceptor complex of photosystem I in spinach chloroplasts. FEBS Lett (1974) 1.29

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia (2009) 1.29

The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int (2006) 1.29

Monitoring changing patterns of drug dependence in accident and emergency departments. Drug Alcohol Depend (1987) 1.29

Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol (2003) 1.28

Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend (2001) 1.27

The stability of cotinine in unfrozen saliva mailed to the laboratory. Am J Public Health (1994) 1.27

Detection of an EPR multiline signal for the S0* state in photosystem II. Biochemistry (1997) 1.27

Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia: an electron microscopy study in the rat. J Cereb Blood Flow Metab (1984) 1.26

Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis (2008) 1.22

Residential status and risk of hip fracture. Age Ageing (1999) 1.22

Nitrogenase activity in cell-free extracts of the blue-green alga, Anabaena cylindrica. J Bacteriol (1971) 1.21

An instrument for measuring coping behaviours in hospitalized alcoholics: implications for relapse prevention treatment. Br J Addict (1983) 1.21

High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int (2008) 1.20

Ferredoxin-dependent carbon assimilation in Rhodospirillum rubrum. Arch Mikrobiol (1967) 1.20

Evidence for the role of a bound ferredoxin as the primary electron acceptor of photosystem I in spinach chloroplasts. Biochim Biophys Acta (1972) 1.18

Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation (1998) 1.18

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend (1995) 1.17

Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr (1986) 1.17

The high prevalence of sexual concerns among women seeking routine gynecological care. J Fam Pract (2000) 1.16

The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone (2008) 1.14

Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs. J Nucl Med (1990) 1.13

A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand (2000) 1.13

Soluble nitrogenase from vegetative cells of the blue-green alga Anabaena cylindrica. Nature (1970) 1.11

Establishment of a new human pneumococcal standard reference serum, 007sp. Clin Vaccine Immunol (2011) 1.11

Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J Clin Invest (2000) 1.09

Mössbauer effect in the ferredoxin of Euglena. Nature (1968) 1.09

1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease. J Bone Miner Res (2000) 1.09

Comment on Kanis et al.: Pitfalls in the external validation of FRAX. Osteoporos Int (2012) 1.09

Hyperfine structure of (57Fe) iron in the Mössbauer spectrum of the high-potential iron protein from Chromatium. Biochem J (1970) 1.09

Osteomalacia after pamidronate for Paget's disease. Lancet (1994) 1.07

Factors influencing the length of hospital stay of patients with heart failure. Eur J Heart Fail (2003) 1.07